2026 Speakers
Luiza Abdo, PhD, Brazilian National Cancer Institute
Mr Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center
Sharon Anderson, VP of Scientific Affairs, Alliance for Regenerative Medicine
Jared Auclair, Director of Bioinnovation, Northeastern University
Daniel Baker, PhD, June Lab, University of Pennsylvania
Christopher Ballas, Global Commercial Lead, Custom Cell Products, Cook MyoSite Inc
Roy Baynes, Executive Vice President and Chief Medical Officer, Eikon Therapeutics
Vladimir Bermudez, Associate Director, Columbia Institute for Cell Engineering and Therapy, Columbia University Irving Medical Center
Sulagna Bhattacharya, CEO, Nanoscope Therapeutics
Anne Brooks, SVP, Global Access, Operations and Proleukin, Iovance Biotherapeutics
Dr Catherine Brownstein, Assistant Professor, Harvard Medical School
Kim Burlison, Head of Market Access, North America, Orchard Therapeutics
Dr. Frederic Bushman, Professor and Chair, Department of Microbiology, Co-Director PennCHOP Microbiome Program, Perelman School of Medicine University of Pennsylvania
Brian Campbell, VP & GM, US, Orchard Therapeutics
Dr. Yu (Clay) Cao, Vice President, Global Head of Drug Discovery, GenEditBio Limited
Daniel Chafamo, M.D. Candidate, Perelman School of Medicine University of Pennsylvania
Ms Therese Choquette, Head of Analytical and Translational Sciences, Tigen Pharma
Michelle Christian, Sr Director of Quality and Technical Operations, KSQ Therapeutics, Inc.
Daniel Cohen, Senior Director, Vector Engineering Genomics and Computational Biology, Roche Innovation Center
Dr Angela Columbano, Head Business Development and Partnership, Genethon
Mike Conway, Vice President, Talent and Learning | People & Culture, Bluerock Therapeutics
Terry Cothran, Chief Pharmacy Officer, Oklahoma Health Care Authority
TJ Cradick, CSO / Principal, Gene Editing Frontiers LLC
Houman Dehghani, Vice President, Technical Development, Cabaletta Bio
Arnaud Deladeriere, President and Principal Consultant, Cell&Gene Consulting
Francesco Destro, Head of Engineering, BioCurie
Wenjun Di, Senior Scientist, Ultragenyx Pharmaceutical Inc.
Dr Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc.
Tracy Dowling, Chief Business Officer & General Counsel, AskBio
Matt Edwards, Vice President, Process Science, Affinia Therapeutics
Dr. Kate Excoffon, Founder and CEO, Gene Tx Optimized, LLC
Steven Feldman, Site Head and Scientific Director, Stanford GMP Facility, Stanford School of Medicine/Stanford HealthCare
Madelyn Fell, Director of Operations, Cell Therapy and Transplant, University of Pennsylvania Health System
Mr Allen Feng, Chief Scientific Officer, HebeCell Corporation
Miguel Forte, CEO, Kiji Therapeutics and President, International Society of Cell and Gene Therapy, Kiji Therapeutics
Patrick Gailliot, Sr. Director, Patient Operations, Abeona Therapeutics
Zhenghong Gao, Chief Strategy Officer, Zhongmou Therapeutics
Maurits Geerlings, President & CEO, NanoCell Therapeutics
Erin Harris, Chief Editor, Cell & Gene
Friederike Herbst-Nowrouzi, Director of the Human Genome Editing Laboratory (HGEL), Perelman School of Medicine University of Pennsylvania
Dr. Spencer Hoover, Principal, SH Consulting LLC
Xiao Huang, Assistant Professor, Precision Immune Engineering Laboratory, Drexel University
Ruud Hulspas, Director Process Development, Dana-Farber Cancer Institute
Scott Jeffers, Chief Technology Officer, GenSight Biologics
Micheala Jones, Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis, Regeneron
Margareth Jorvid, Board Member, Elicera Therapeutics
Manoj Kandpal, Director of Research Bioinformatics at the Center for Clinical and Translational Science, Rockefeller University
William Kearns, Co-founder & CSO, Lugenica
Chirag Khatiwala, Independent Advisor, Independent
Koby Kidder, Principal Scientist & Co-Inventor, BobcatBio
Daniel KIlbank, CSO, Mygogenesis LLC
Dr Sven Kili, Partner, Saisei Ventures
Dr. Eric Kmiec, Founder & CEO, Corrixr Therapeutics
Dr Richard Koya, Professor, University of Chicago School of Medicine, University of Chicago
Stephan Krause, Executive Director, Analytical Strategy, Bristol Myers Squibb
Tom Leitch, CTO, KSQ Therapeutics, Inc.
Roy Levitt, Clinical Professor, Director, UHealth Institute for Advanced Pain Management Center, UNIVERSITY OF MIAMI
George Magrath, CEO, Opus Genetics
Craig Martin, Founder, CEO, Orphan Therapeutics Accelerator
Mukesh Mayani, Senior Director, Global CMC Development, Ultragenyx
Joshua McGee, CSO & Co-founder, Keylicon Biosciences
Michael McMahon, Professor, Johns Hopkins School of Medicine and Kennedy Krieger Institute, John Hopkins School Of Medicine
Fiona Miller, Managing Partner, quadraScope Ventures
Avanish Mishra, Assistant Professor of Bioengineering, Harvard Medical School
Dara Missan, Lead Engineer, QC, Mayo Clinic
Dora Mitchell, Senior Vice President of Operations, Chief of Staff, Interius BioTherapeutics, Inc.
Dr Samarendra Mohanty, President and Chief Scientific Officer, Nanoscope Therapeutics
Prachi Narayan, Independent Expert, Independent Expert
Parul Nisha, Senior Director, Clinical and Medical Affairs, Cook MyoSite Inc
Natascha Nolet, Sr. Manager, Abeona Therapeutics
Ms Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)
Parimal Pande, Associate Director, Genetic Safety, Cell & Gene Therapy, Johnson and Johnson Innovative Medicine
Andrea Penn, Commercial Learning & Development Director, Autolus
Dr Shahrooz Rabizadeh, CEO & Co-Founder, Sagittarius Bio, Inc
Niraj Ramachandran, Senior Regulatory Program Director - Cellular Therapies Pharma Technical Cell and Gene Therapy (PTC), Genentech
Brock Reeve, CEO, Eos BioInnovation
Michael Riotto, Grassroots Advocacy Leader, International Myeloma Foundation
Natalia Rivera-Torres, Associate Director of Pre-Clinical Development & Research Operations, Gene Editing Institute
Irene Rombel, President and CEO, BioCurie
Mr Roelof Rongen, CEO, Adolore Biotherapeutics
Dr. Qian Ruan, SVP of Technical Operations, Arcturus Therapeutics
Holger Russ, Scientific Co-Founder, TOLERANCE BIO
Tay Salimullah, Venture Partner, 4BIO Capital
Amber Salzman, Chief Executive Officer, Epicrispr Biotechnologies
Vishal Shah, Dean, Division of the Math, Science and Health Careers, Community College of Philadelphia
Dr. Justin Skoble, Vice President of Technical Operations, Caribou Biosciences
Shankar Swaminathan, Team Lead Drug Product Readiness CMC, Astellas
Kelli Tea, Head of Commercial, Cartesian Therapeutics
Sally Tucker, Chief Medical Officer, Opus Genetics
Dr. Jim Wang, VP, Global Regulatory Strategy, Genetic Medicines, Regeneron
Jie Wei, Director, Bioanalytical Sciences, Tr1x, Inc
Daniel Weiss, Professor, University of Vermont
Morgan Wolfe, Associate Director, Patient Operations, Abeona Therapeutics
Karrie Wong, VP of Cell Therapy, KSQ Therapeutics, Inc.
Howard Wu, Co-Founder & Chief Scientific Officer, Full Circles Therapeutics
Lingyue yan, Scientist III, AbbVie
David Zuzga, Associate Dean of Biomedical Studies, The Wistar Institute
Get Involved with the Advanced Therapies Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events